XML 80 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Divestitures
12 Months Ended
Sep. 30, 2012
Divestitures

Note 10 — Divestitures

On April 10, 2012, the Company signed a definitive agreement to sell its BD Biosciences — Discovery Labware unit, excluding its Advanced Bioprocessing platform, to Corning Incorporated, the world leader in specialty glass and ceramics. This sale was completed on October 31, 2012 and gross cash proceeds from the sale were approximately $728,000, subject to post-closing adjustments. The Company expects to record a gain on the sale within discontinued operations in the first quarter of fiscal year 2013.

Assets held for sale associated with the Discovery Labware disposal group included the following at September 30, 2012:

 

Inventory

   $ 49,818   

Other current assets

     449   

Property, plant and equipment, net

     76,732   

Other intangibles, net

     8,858   
  

 

 

 

Assets held for sale

   $ 135,857   
  

 

 

 

In the fourth quarter of fiscal year 2010, the Company sold the Ophthalmic Systems unit and the surgical blades, critical care and extended dwell catheter product platforms for $270,000. The Company recognized a pre-tax gain on sale from all of these divestitures of $146,478.

The results of operations associated with the Discovery Labware disposal group, Ophthalmic Systems unit, surgical blade platform and critical care platform are reported as discontinued operations for all periods presented in the accompanying Consolidated Statements of Income and Cash Flows and related disclosures. The Company agreed to perform contract manufacturing for a defined period after the sale of the extended dwell catheter product platform. The conditions for reporting the results of this platform in discontinued operations were not met and as such, the associated results of operations were reported within continuing operations and $18,197 of the gain on sale from the 2010 divestitures was recognized in Other income (expense).

Results of discontinued operations, which were primarily associated with the Discovery Labware disposal group, for the years ended September 30 were as follows:

 

     2012      2011      2010  

Revenues

   $ 238,376       $ 248,016       $ 415,668   
  

 

 

    

 

 

    

 

 

 

Income from discontinued operations before income taxes

     91,667         105,310         276,392   

Less income tax provision

     31,268         35,199         73,626   
  

 

 

    

 

 

    

 

 

 

Income from discontinued operations, net

   $ 60,399       $ 70,111       $ 202,766